• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    NOVONIX Limited - American Depository Shares (NQ: NVX )

    2.050 +0.070 (+3.54%)
    Streaming Delayed Price Updated: 9:47 AM EST, Nov 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about NOVONIX Limited - American Depository Shares

    < Previous 1 2 3 4 5 6 Next >
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
    Via Benzinga
    NOVONIX to Commence Trading on Nasdaq through Level II ADR Program
    From NOVONIX Limited
    Via Business Wire
    White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
    The U.S. will invest $3 billion in the COVID-19 vaccine supply chain within the coming weeks, White House coronavirus response coordinator Jeff Zients said Thursday.... 
    Via Benzinga
    Exposures COVID-19
    Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer
    According to findings from a new U.K. study, along with reducing the risk of severe disease and hospitalization, COVID-19 vaccines can also lower the odds of having long-term... 
    Via Benzinga
    Exposures COVID-19
    EU Says Without EMA Approval COVID-19 Boosters May Face Higher Legal Risks: Reuters
    European Union countries that decide to use COVID-19 vaccine booster shots may face increased legal risks, the European Commission said. Related Content: Pfizer, BioNTech... 
    Via Benzinga
    Exposures COVID-19
    COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ
    Researchers have pointed a handful of amino acids targeted by key antibodies of some people who received the AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine... 
    Via Benzinga
    Exposures COVID-19
    AstraZeneca COVID-19 Vaccine Shows Higher Immune Response With Longer Gap, Third Booster Dose
    A sub-analysis from the Oxford-led COV001 and COV002 trials with AstraZeneca Plc (NASDAQ: AZN) COVID-19 vaccine induced strong immune responses following... 
    Via Benzinga
    Exposures COVID-19
    CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed
    CureVac BV (NASDAQ: CVAC) said its first-generation COVID-19 vaccine candidate had passed its first interim analysis, but it was not yet ready to share efficacy data.... 
    Via Benzinga
    Exposures COVID-19
    Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move
    The closely watched issue of patent rights for COVID-19 vaccines garnered headlines again as the Biden administration came out in favor of a proposal at the World Trade... 
    Via Benzinga
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents
    Novavax Inc (NASDAQ: NVAX) has initiated a pediatric expansion of its Phase 3 PREVENT-19 trial for NVX-CoV2373, its COVID-19 vaccine candidate. The additional... 
    Via Benzinga
    Exposures COVID-19
    Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
    Emergent BioSolutions Inc (NYSE: EBS) said it hopes to respond to U.S. regulators within days on how to resolve the problems at its Baltimore plant, which have forced... 
    Via Benzinga
    Exposures Product Safety
    Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters
    BioNTech SE's (NASDAQ: BNTX) CEO Ugur Sahin says the company, along with its partner Pfizer Inc (NYSE: PFE), could have data from trials testing the... 
    Via Benzinga
    Exposures COVID-19
    US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses
    The United States will start to share up to 60 million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine doses with other countries as they become... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.